To recognize MRSA Awareness Month through October, here are 5 critical facts about MRSA that everyone needs to know.
The PCAST Patient Safety Report Unpacked (Part 2): All About Evidence-Based Solutions
by Erica Mitchell | September 25 2023
In our last post, we introduced the President's Council of Advisors on Science and Technology (PCAST) report on patient safety. Today we will focus on how hospital-associated infections are specifically addressed in the report and the report's emphasis on evidence based solutions to address HAIs and other preventable harm to patients.
Grassroots Organizations: On Your Side in the Fight Against HAIs
by Erica Mitchell | September 20 2023
Those of us who work in the field of infection control have a lot on our minds: Surveillance, efficacy, new studies, data, policy, finances... the list goes on. There is one important aspect of infection control that should never leave our minds, however - the patient. Today's post focuses on the support and advocacy groups whose sole function is to keep the patient's experience front and center.
The President’s Council of Advisors on Science and Technology: The Patient Safety Report Unpacked
by Erica Mitchell | September 15 2023
This past month, the President's Council of Advisors on Science and Technology (PCAST) submitted a report focused on recommendations around patient safety. In today's post, we'll explore who PCAST is, how they pulled together the report, their main recommendations, and in a future post, we will examine what this could mean for our nation's approach to infection control and prevention. Let's dive in!
How can a simple infection lead to organ failure and death in the span of a few days? The answer lies not in the pathogen causing the infection (although it may play a role), or even the severity of the infection, but rather in the body's overreaction to the infection. In today's post, we will look at what causes sepsis, the early warning symptoms, as well as what is being done to prevent deaths due to this frightening condition.
With a few words, a family's life is forever changed: "It's cancer." For any patient, these words bring anxiety and fear. When that patient is a child, however, no words can express the emotions that send shock waves through a family, friends, and community. Today's post begins a three-part story of one such young patient, a little boy named Jack. (Best of all, Jack's story has a happy ending.) During Childhood Cancer Awareness Month join us as we see the challenges of pediatric cancer treatment and infection control through the eyes of a boy and his mother.
Infection Control Innovations: Making the Value Proposition that Survives Cost-Cutting
by Erica Mitchell | September 3 2023
The perceived stability of the national economy impacts the willingness of the healthcare industry to invest in innovations with up-front costs. In times of relative economic stability, healthcare systems may be more willing and able to make up-front investments with returns that pay off in the short- and long-term. During times of more economic instability, healthcare systems may opt to pass on these same innovations in their efforts to cut immediate costs. What can make the difference? Quality data at sufficient quantity can mitigate risk-aversion during times of instability. In today's post, we will explore how to make the value proposition for infection control innovations even during times of economic volatility.